Abstract
To investigate liver cancer-associated genes and to explore the molecular basis of liver cancer genesis, we have cloned a novel hepatocellular carcinoma (HCC)-related gene with a transcript of 2520 base pairs in length named HCCA2 by mRNA differential display polymerase chain reaction (DDPCR) and screening a placenta cDNA library. No significant homologous protein with known genes was found. Western blot analysis showed that HCCA2 could be expressed in transfected 293 cells. Northern hybridization analysis showed that HCCA2 mRNA was expressed in 79% (34/43) patients with HCC, most of whom had significantly high expression in HCC tissues, while not expressed in corresponding noncancerous liver tissues. The clinical pathological data showed that the HCCA2 was significantly associated with the invasion of tumour capsule (P= 0.0007) and the expression of ki-67 protein (P= 0.0022). Immunohistochemical staining confirmed that the HCCA2 protein was localized in cytoplasm of liver cancer tissues. According to amino acid analysis of the protein and its localization, it may play a role in a cascade of intracellular signal transduction because the protein was characterized with two Src homology 3 (SH3) binding-domains and several functional motifs of phophorylation. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bain I and McMaster P (1997) Benign and malignant liver turnouts. Surgery 15: 169–174
Chomczinski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Bilchem 162: 156–161
Cohen GB, Ren R and Baltimore D (1995) Modular binding domains in signal transduction proteins. Cell 80: 237–248
Duvoux C (1998) Epidemiology and diagnosis of HCC in cirrhosis. Ann Chir 52: 511–517
Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP and Thorgeirsson SS (1994) Alteration of tumor suppressor genes and allelic losses in human hepatocellular carcinoma in China. Cancer Res 54: 281–285
Graves JD and Krebs EG (1999) Protein phosphorylation and signal transduction. Pharmacol Ther 82: 111–121
Hui AM and Makuuchi M (1999) Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. Scand J Gastroenterol 34: 737–742
Irene ON (1998) Molecular and cellular pathology of hepatocellular carcinoma. J Gastronenterol Hepatol 13: S299–S303
Johnson RC (1997) Hepatocellular carcinoma. Hepatogastroenterology 44: 307–312
Kaita KD, Pettigrew N and Minuk GY (1997) Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue. Liver 17: 13–16
Kang H, Freund C, Duke-Cohan JS, Musacchio A, Wagner G and Rudd CE (2000) SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55. EMBO J 19: 2889–2899
Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M and Yamamoto M (1999) Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59: 4990–4996
Kozak M (1989) The scanning model for translation: an update. J Cell Biol 108: 229–241
Liang P and Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science 257: 967–971
Liang P, Averboukh L and Pardee AB (1993) Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 21: 3269–3275
Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3: 231–234
Myllyharju J and Kivirikko KI (1999) Identification of a novel proline-rich peptide-binding domain in prolyl 4-hydroxylase. EMBO J 18: 306–312
Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T and Yamaguchi K (1999) Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett 140: 227–234
Ozturk M (1999) Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19: 235–242
Schlott T, Ahrens K, Ruschenburg I, Reimer S, Hartmann H and Droese M (1999) Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. Br J Cancer 80: 73–78
Sherman M (1995) Hepatocellular carcinoma. Gastroenterology 3: 55–66
Tiniakos DG and Brunt EM (1999) Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study. Liver 19: 58–68
Wallner I, Hartmann H and Ramdori G (1994) Current therapeutic strategies in HCC, Part 1. Leber Magen Darm 24: 150–154
Wang HY, Lian ZR, Lerch MM, Chen ZJ and Ullrich A (1996) Characterization of PCP-2, A Novel Receptor Protein Tyrosine Phosphatase of the MAM Domain Family. Oncogene 12: 2555–2562
Wang HY, Fuchs M, Ciossek T, Chen ZJ and Ullrich A (1998) MAM-Subfamily Protein Tyrosine Phosphatases during Mouse Development. Mechanisms of Development 70: 91–109
Xu GW, Sun ZT, Forrester K, Wang XW, Coursen J and Harris CC (1996) Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild type p53 gene. Hepatology 24: 1264–1268
Zhang H, Zhang R and Liang P (1996) Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res 24: 2454–2455
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Wang, ZX., Wang, HY. & Wu, MC. Identification and characterization of a novel human hepatocellular carcinoma-associated gene. Br J Cancer 85, 1162–1167 (2001). https://doi.org/10.1054/bjoc.2001.2059
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2059
Keywords
This article is cited by
-
Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2
Molecular and Cellular Biochemistry (2007)
-
HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma
Oncogene (2006)
-
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
Oncogene (2006)
-
Antisense overexpression of BMAL2 enhances cell proliferation
Oncogene (2003)
-
The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma
Journal of Cancer Research and Clinical Oncology (2003)